M&A Deal Summary

NuVasive Acquires Simplify

On February 25, 2021, NuVasive acquired medical products company Simplify from EQT Life Sciences

Acquisition Highlights
  • This is NuVasive’s 7th transaction in the Medical Products sector.
  • This is NuVasive’s 9th transaction in the United States.
  • This is NuVasive’s 2nd transaction in California.

M&A Deal Summary

Date 2021-02-25
Target Simplify
Sector Medical Products
Buyer(s) NuVasive
Sellers(s) EQT Life Sciences
Deal Type Add-on Acquisition
Advisor(s) J.P. Morgan Securities (Financial)
Wilson Sonsini Goodrich & Rosati
Johnson Winter & Slattery (Legal)

Target

Simplify

Sunnyvale, California, United States
Simplify is a medical device company focused on cervical spinal disc arthroplasty, using innovative, MRI-compatible materials designed to optimize diagnostic imaging and decrease the need for ionizing radiation. Simplify was founded in 2013 and is based in Sunnyvale, California.

Search 215,029 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

NuVasive

San Diego, California, United States

Category Company
Founded 1997
Sector Medical Products
Revenue 1.2B USD (2022)
DESCRIPTION
Entrance to NuVasive's corporate headquarters in San Diego, California.
Entrance to NuVasive's corporate headquarters in San Diego, California.

NuVasive is a medical device company focused on the design, development, and marketing of products for the surgical treatment of spine disorders. NuVasive was formed in 1997 and is based in San Diego, California.


DEAL STATS #
Overall 10 of 10
Sector: Medical Products M&A 7 of 7
Type: Add-on Acquisition M&A Deals 9 of 9
State: California M&A 2 of 2
Country: United States M&A 9 of 9
Year: 2021 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2017-12-12 SafePassage

New York, New York, United States

SafePassage is a provider of intraoperative neurophysiological monitoring (IONM) services. SafePassage was founded in 2007 and is based in New York, New York.

Buy -

Seller(S) 1

SELLER

EQT Life Sciences


Category Growth Capital Firm
Founded 1987
PE ASSETS 3.5B EUR
Size Large
Type Sector Focused
DESCRIPTION

EQT Life Sciences (formerly Life Science Partners) is a private investment firm focused on growth and venture capital financing for life sciences and healthcare companies. The Firm targets early to mid?stage companies in sectors such as therapeutics, medical devices, diagnostics, healthtech, and biotech. EQT Life Sciences was formed in 1986 and is headquartered in Amsterdam, the Netherlands.


DEAL STATS #
Overall 2 of 10
Sector: Medical Products M&A 1 of 3
Type: Add-on Acquisition M&A Deals 1 of 7
State: California M&A 1 of 2
Country: United States M&A 1 of 4
Year: 2021 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-01-20 Neurent Medical

Galway, Ireland

Neurent Medical is pioneering innovative treatments for chronic inflammatory sino-nasal diseases by targeting and safely disrupting hyperactive parasympathetic nerves that drive underlying inflammation. Neurent Medical is based in Galway, Ireland.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-03-22 XyloCor Therapeutics

Wayne, Pennsylvania, United States

XyloCor Therapeutics, a private clinical-stage biopharmaceutical company focused on the development of gene therapy for the significant unmet patient needs in advanced coronary artery disease. XyloCor Therapeutics was founded in 2013 and is based in Wayne, Pennsylvania.

Buy -